Noble E. Jarrell

Array ( [id] => 5515704 [patent_doc_number] => 20090216011 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-27 [patent_title] => 'Synthesis of cyclen derivatives' [patent_app_type] => utility [patent_app_number] => 11/911848 [patent_app_country] => US [patent_app_date] => 2006-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3634 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20090216011.pdf [firstpage_image] =>[orig_patent_app_number] => 11911848 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 83864 [patent_doc_number] => 07741358 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-22 [patent_title] => 'Crystal form of asenapine maleate' [patent_app_type] => utility [patent_app_number] => 11/399204 [patent_app_country] => US [patent_app_date] => 2006-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4496 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/741/07741358.pdf [firstpage_image] =>[orig_patent_app_number] => 11399204 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5297252 [patent_doc_number] => 20090012178 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-08 [patent_title] => 'Benzoxazocines and Their Therapeutic Use' [patent_app_type] => utility [patent_app_number] => 11/817200 [patent_app_country] => US [patent_app_date] => 2006-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4110 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0012/20090012178.pdf [firstpage_image] =>[orig_patent_app_number] => 11817200 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6590446 [patent_doc_number] => 20100130473 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-27 [patent_title] => 'COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 11/817134 [patent_app_country] => US [patent_app_date] => 2006-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22000 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20100130473.pdf [firstpage_image] =>[orig_patent_app_number] => 11817134 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5683534 [patent_doc_number] => 20060199804 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-07 [patent_title] => 'Compounds' [patent_app_type] => utility [patent_app_number] => 11/361599 [patent_app_country] => US [patent_app_date] => 2006-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22047 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0199/20060199804.pdf [firstpage_image] =>[orig_patent_app_number] => 11361599 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 217293 [patent_doc_number] => 07612203 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-11-03 [patent_title] => 'Rosuvastatin and salts thereof free of rosuvastatin alkylether and a process for the preparation thereof' [patent_app_type] => utility [patent_app_number] => 11/360289 [patent_app_country] => US [patent_app_date] => 2006-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8120 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/612/07612203.pdf [firstpage_image] =>[orig_patent_app_number] => 11360289 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5000389 [patent_doc_number] => 20070043023 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-22 [patent_title] => 'Modulators of muscarinic receptors' [patent_app_type] => utility [patent_app_number] => 11/359960 [patent_app_country] => US [patent_app_date] => 2006-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 61376 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0043/20070043023.pdf [firstpage_image] =>[orig_patent_app_number] => 11359960 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4496324 [patent_doc_number] => 07947675 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-24 [patent_title] => 'Trifluoromethylbenzamide derivatives and therapeutic uses thereof' [patent_app_type] => utility [patent_app_number] => 11/908712 [patent_app_country] => US [patent_app_date] => 2006-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9382 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/947/07947675.pdf [firstpage_image] =>[orig_patent_app_number] => 11908712 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5643267 [patent_doc_number] => 20060281722 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-14 [patent_title] => 'Compounds and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/352846 [patent_app_country] => US [patent_app_date] => 2006-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19610 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 24 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20060281722.pdf [firstpage_image] =>[orig_patent_app_number] => 11352846 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5667624 [patent_doc_number] => 20060172974 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-03 [patent_title] => 'Crystalline forms of 1-benzoyl-4-[2-[4,7-dimethoxy-1-[(phosphonooxy)methyl]-1H-pyrrolo[2,3-C]pyridin-3-yl]-1,2-dioxoethyl]-piperazine' [patent_app_type] => utility [patent_app_number] => 11/340032 [patent_app_country] => US [patent_app_date] => 2006-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 13770 [patent_no_of_claims] => 68 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20060172974.pdf [firstpage_image] =>[orig_patent_app_number] => 11340032 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4507829 [patent_doc_number] => 07915249 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-03-29 [patent_title] => 'Heterocyclic tetracyclic tetrahydrofuran derivatives as 5HT2 inhibitors in the treatment of CNS disorders' [patent_app_type] => utility [patent_app_number] => 11/814432 [patent_app_country] => US [patent_app_date] => 2006-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11329 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/915/07915249.pdf [firstpage_image] =>[orig_patent_app_number] => 11814432 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5596920 [patent_doc_number] => 20060160838 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-20 [patent_title] => 'Macrocyclic analogs for the treatment of immunoregulatory disorders and respiratory diseases' [patent_app_type] => utility [patent_app_number] => 11/334858 [patent_app_country] => US [patent_app_date] => 2006-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15368 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20060160838.pdf [firstpage_image] =>[orig_patent_app_number] => 11334858 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4833930 [patent_doc_number] => 20080132477 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-05 [patent_title] => 'Macrocyclic Compounds Useful as Bace Inhibitors' [patent_app_type] => utility [patent_app_number] => 11/794413 [patent_app_country] => US [patent_app_date] => 2006-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 61111 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0132/20080132477.pdf [firstpage_image] =>[orig_patent_app_number] => 11794413 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4786475 [patent_doc_number] => 20080139804 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-12 [patent_title] => 'Photosensitive Compounds' [patent_app_type] => utility [patent_app_number] => 11/795160 [patent_app_country] => US [patent_app_date] => 2006-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 2279 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0139/20080139804.pdf [firstpage_image] =>[orig_patent_app_number] => 11795160 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5619405 [patent_doc_number] => 20060188938 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-24 [patent_title] => 'Compounds for inhibiting beta-amyloid production and methods of identifying the compounds' [patent_app_type] => utility [patent_app_number] => 11/328470 [patent_app_country] => US [patent_app_date] => 2006-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 38231 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0188/20060188938.pdf [firstpage_image] =>[orig_patent_app_number] => 11328470 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 232824 [patent_doc_number] => 07598249 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-10-06 [patent_title] => 'Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase' [patent_app_type] => utility [patent_app_number] => 11/321710 [patent_app_country] => US [patent_app_date] => 2005-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30614 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/598/07598249.pdf [firstpage_image] =>[orig_patent_app_number] => 11321710 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5620094 [patent_doc_number] => 20060189628 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-24 [patent_title] => 'Compounds useful as chemokine receptor antagonists' [patent_app_type] => utility [patent_app_number] => 11/320298 [patent_app_country] => US [patent_app_date] => 2005-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 46594 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0189/20060189628.pdf [firstpage_image] =>[orig_patent_app_number] => 11320298 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 334409 [patent_doc_number] => 07507821 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-03-24 [patent_title] => 'Process for preparing Imatinib' [patent_app_type] => utility [patent_app_number] => 11/318455 [patent_app_country] => US [patent_app_date] => 2005-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3557 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/507/07507821.pdf [firstpage_image] =>[orig_patent_app_number] => 11318455 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5023816 [patent_doc_number] => 20070149782 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-28 [patent_title] => 'Methods of preparing a crystalline form of 7-(4-chlorobutoxy)-3,4-dihydro-2(1h)-quinolinone and the use thereof in the synthesis of Aripiprazole' [patent_app_type] => utility [patent_app_number] => 11/315230 [patent_app_country] => US [patent_app_date] => 2005-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 3403 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0149/20070149782.pdf [firstpage_image] =>[orig_patent_app_number] => 11315230 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5650035 [patent_doc_number] => 20060135770 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-22 [patent_title] => 'PARP inhibitors' [patent_app_type] => utility [patent_app_number] => 11/315528 [patent_app_country] => US [patent_app_date] => 2005-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18169 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0135/20060135770.pdf [firstpage_image] =>[orig_patent_app_number] => 11315528 [rel_patent_id] =>[rel_patent_doc_number] =>)